<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="8069">Luminal</z:chebi> delivery of <z:chebi fb="0" ids="26025">phosphatidyl</z:chebi> rich <z:chebi fb="1" ids="16247">phospholipids</z:chebi> appears to reduce mucosal inflammatory activity in a high proportion of patients with chronically active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The simplicity and apparent safety of this therapeutic approach offers new insights into the importance of the mucus barrier in the pathogenesis and treatment of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
</text></document>